Literature DB >> 2211010

Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation.

D A Lee1, T C Lee, A E Cortes, S Kitada.   

Abstract

Scar formation and fibrosis are the most common causes of ultimate glaucoma filtration surgery failure. The authors used Coulter counter, hexosaminidase, and 3H-thymidine assays to evaluate the effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast growth in tissue culture. Fifty percent inhibitory doses (ID50) for each drug on different days of incubation with fibroblasts were calculated with these three assays. Among these four drugs only daunorubicin exerted a significant effect on cellular attachment, showing cytotoxicity at 4 x 10(-6) M. However, all drugs had antiproliferative effects. Daunorubicin was the most potent drug in the concentration range studied. Mithramycin had a narrow therapeutic range in tissue culture. Cellular antiproliferative responses to mitomycin and bleomycin were more gradual. These drugs have potential applications in the prevention of glaucoma filtration surgery failure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211010

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  21 in total

1.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  Decorin and suramin inhibit ocular fibroblast collagen production.

Authors:  H Mietz; P Chévez-Barrios; M W Lieberman; M Wendt; R Gross; S F Basinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

3.  Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias.

Authors:  E G Kemp; A N Harnett; S Chatterjee
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

4.  Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro.

Authors:  S Saika; A Ooshima; O Yamanaka; Y Okada; S Tanaka; Y Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

5.  Results of intraoperative mitomycin C application in dacryocystorhinostomy.

Authors:  S L Liao; S C Kao; J H Tseng; M S Chen; P K Hou
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

6.  Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery.

Authors:  S Grisanti; M Diestelhorst; K Heimann; G Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

7.  Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.

Authors:  P T Finger; G Czechonska; S Liarikos
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

8.  Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.

Authors:  R Rachmiel; H Leiba; S Levartovsky
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

9.  Growth inhibition of human Tenon's capsule fibroblasts and rabbit dermal fibroblasts with non-carcinogenic N-alkylated anthracyclines.

Authors:  U H Steinhorst; E P Chen; S F Freedman; R Machemer; D L Hatchell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-06       Impact factor: 3.117

10.  Transconjunctival penetration of mitomycin C.

Authors:  T Velpandian; Ramanjit Sihota; Ankur Sinha; Viney Gupta
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.